Archive for the ‘Peritoneal Mesothelioma’ Category

Three Types of Mesothelioma Cancer

Wednesday, August 25th, 2010

There are three types of mesothelioma cancer. This is called a pleural effusion, if the lung disease, affects the abdominal peritoneal effusion and pericardial, if effects on the heart. About 75% of cases of pleural mesothelioma and 20% are peritoneal or pericardial effusion. There are also some other rare types of mesothelioma, the remaining 5%. All these statistics are poorly documented. There are many cases that are undiagnosed or unreported in the world:

Pleural mesothelioma:
Among the various types of cancer, mesothelioma occupy only a small percentage. However, among the various types of mesothelioma, pleural mesothelioma makes about three to four cases documented. In the fluid between the chest and the mesothelium lining is constructed.

Peritoneal mesothelioma:
Peritoneal Mesothelioma is a rare disease. Approximately 10-20% of documented cases of peritoneal mesothelioma diagnosed with mesothelioma. Types of mesothelioma affects the stomach of the patient. Abdominal mesothelial cells do not function properly in this sickness. The disease is caused by inhaling asbestos fibers through the mouth.

Pericardial Mesothelioma:

The rarest of mesothelioma, pericardial mesothelioma, mesothelial layer that affects the liver. The main symptoms of pericardial mesothelioma are chest pain, shortness of breath, fever, heart palpitations, fatigue and cough. Like all types of mesothelioma, there is no cure for this species doctors nothing I can do is pain and discomfort symptoms and help patients reduce comfortable and quiet death.

Tags: , , ,
Posted in Kinds of Mesothelioma, Peritoneal Mesothelioma | No Comments »

Documented cases of peritoneal mesothelioma diagnosed

Wednesday, August 4th, 2010

Peritoneal mesothelioma

Peritoneal mesothelioma:
Peritoneal Mesothelioma is a rare disease. Approximately 10-20% of documented cases of peritoneal mesothelioma diagnosed with mesothelioma. Types of mesothelioma affects the stomach of the patient. Abdominal mesothelial cells do not function properly in this sickness. The disease is caused by inhaling asbestos fibers through the mouth. The fibers travel through the digestive tract and parts of the digestive system processed. The layer of the mesothelium in rapidly dividing cells and lasts longer.

This leads to stomach cancer and also other parts of the body. To resolve the most important symptoms of peritoneal mesothelioma, abdominal pain, nausea, vomiting, constipation, fever, chest pain, weight loss and problems. The majority of movement or constipation, bloating and abdominal tissue sections are the classic signs of peritoneal mesothelioma. The disease is under various forms by using X-ray scanners, diagnosed by MRI, PET, laparoscopy, laparotomy, thoracotomy, and so on. The main risk factors for this disease is exposure to asbestos fibers and asbestos dust.

However, the following factors also increase the risk of this disease:
* A family history of risk factors for children with cancer.
* A smoker, the increased risk of contracting the disease than non-smokers, which seems to have the same level and amount of exposure to asbestos fibers.
* The zeolite is a mineral that is very similar to asbestos from properties and it seems as dangerous as asbestos.
* Thorium dioxide is used in X-rays and a trigger for cancer.

Tags: , ,
Posted in Diagnosis, Peritoneal Mesothelioma | No Comments »

Chemotherapy Treatments

Thursday, June 3rd, 2010

Chemotherapy involves the use of anti-cancer drugs that act by preventing cell division of cancer cells. In most cases, drug combinations are used to increase the effectiveness. Chemotherapy may be used aggressively to shrink the tumor, or palliative, to relieve symptoms such as shortness of breath or pain. The chemotherapy can be administered by injection into a vein or muscle, by administration via the mouth or sometimes by direct administration into the pleural or peritoneal cavity. Some of the most commonly used drugs are:

  • Pemetrexed (Alimta)
  • Cisplatin (Platinol)
  • Carboplatin (Paraplatin)
  • Gemcitabine (Gemzar)
  • Doxorubicin (Adriamycin)
  • Mitomycin
  • Raltitrexed (Tomudex)
  • Vinorelbine (Navelbine)

Constantly new drugs are tested by pharmaceutical companies, so you can ask your doctor any time of the latest and most promising drugs. Such a drug, Alimta (pemetrexed), was approved in September 2005 in Europe.

Tags: , ,
Posted in Treatments | No Comments »

Clinical Presentation for Patient Mesothelioma

Sunday, May 9th, 2010

Found cases diagnosed during years of psychopathology, to start their disease with symptoms such as generalized fatigue, slowly chewing and swallowing difficulty leading to a denial of ingesta, weakness in the arms raised (decreased grooming and hair daily), weakness of pelvic girdle (avoidance of walking) and reduction of facial expression. In fact up to 20% are confused in his debut with pathologies psiquiatricas, being the group of young women suffered most from this delay in diagnosis. In addition, the subjective perception of muscle weakness
cular for the patient can lead to anxiety, depression and even phobia social when the involvement of facial muscles is severe.
This difficulty to guide the subtle early symptoms greatly delayed diagnosis and treatment is therefore correct, if not essential to healing, they achieve a better quality of life and better prognosis final

Tags: , , ,
Posted in Clinical Presentation | No Comments »

Synthesis Antibodies

Friday, May 7th, 2010

The fundamental disorder is a decrease in the number of acetylcholine receptors and a flattening of the folds in the postsynaptic membrane.
Although the details of the origin of the synthesis of these autoantibodies remains esclarecer7, there is evidence of the role of the thymus in their training. Over 70% of patients have thymic hyperplasia and thymoma up to 10-15%. Probably start the autoimmune reaction in this organ, but reactive T cells migrate in early stages of disease to other localizaciones8. When the disease appears in people over 50 years there is a special immunological presence of striated muscle antibodies in 50% of casos9. This is considered a marker for autoantibody presence of thymoma associated

Tags: , , ,
Posted in Clinical Presentation | No Comments »

Medical Center Service

Sunday, May 2nd, 2010

Continuing with our philosophy of innovation in services for health care we started renovation work of our facilities, which have included several changes within the clinic and we inaugurated the new San Felipe Medical Center in Camacho.

Thus, these changes have been reflected internally in the modernization of our infrastructure and purchase equipment with the latest technology for various areas.

All this effort is to ensure that our patients receive the best medical care in an environment more in line with modern medicine. It is without doubt, to offer our patients all possible facilities so they can feel a high quality care.

Tags: , , , ,
Posted in Clinical Presentation | No Comments »

Mesothelioma Clinical Trials

Wednesday, April 21st, 2010

mesotheliom clinical trialsClinical trials are studies of promising new treatment for mesothelioma in a particular disease. These tests are the current needs of patients who are willing these experimental treatments for mesothelioma before they are approved by the FDA for testing.
(more…)

Tags: , , , ,
Posted in Peritoneal Mesothelioma | No Comments »

Diagnosis of malignant mesothelioma

Wednesday, April 7th, 2010

diagnosa of malignant mesotheliomaThe diagnosis of malignant mesothelioma is often difficult, the most common differential diagnosis with reactive pleural disorders and metastatic adenocarcinoma. Has recently been shown that serum levels of soluble mesothelin are very specific and moderately sensitive for mesothelioma.

Most mesothelioma patients have exudative effusions of the pleura or peritoneum, which is why these spills are decisive in determining with certainty whether or not someone has the disease.

Tags: , ,
Posted in Diagnosis, Mesothelioma | No Comments »

Treatment of Peritoneal Mesothelioma

Saturday, February 27th, 2010

Currently, therapeutic approaches vary in each institution. Common methods include palliative surgery, systemic chemotherapy, intra-abdominal chemotherapy and surgery cytoreducing with preoperative intraperitoneal chemotherapy.

The agents commonly used in chemotherapy regimens including various combinations of cisplatin, irinotecan, cyclophosphamide, doxorubicin, dacarbazine, gemcitabine and pemetrexed. Before 2003, most of the institutions relied on evidence from small phase II studies and patients treated with cisplatin and gemcitabine. This provided a median survival of 6-9 months. Since then, large trials have taken place and, more recently, has shown that the combination of cisplatin and pemetrexed leads to a median survival of 12-14 months. However, although encouraging, these results indicate that treatment of peritoneal mesothelioma with systemic chemotherapy still has a median survival of only 1 year. This is similar to what occurs in patients who are treated with a palliative approach. Therefore, their effectiveness as first line treatment is questionable. However, it is still a useful option for patients who are not appropriate surgical candidates.
(more…)

Tags: , , , ,
Posted in Peritoneal Mesothelioma, Treatments | No Comments »

Diagnosis of Peritoneal Mesothelioma

Friday, February 26th, 2010

The workup for a patient who is suspected of having peritoneal mesothelioma is similar to any other intra-abdominal cancer. The study includes a set of standard non-invasive tests such as routine laboratory tests, serum tumor markers and computed tomography (CT) scan of chest, abdomen and pelvis.

The routine laboratory tests are often not useful for diagnosis of peritoneal mesothelioma. Useful tumor markers for diagnosis and monitoring of peritoneal mesothelioma include CA 125 and CA 15-3. Among these, the CA 125, which is commonly elevated in cancers of the peritoneal surface and in the ovary, has proved the most useful, with a diagnostic sensitivity of 53.5%. The diagnostic sensitivity of CA 15-3 is usually high in breast cancer is 48.5% and is occasionally used in peritoneal mesothelioma. Other tumor markers such as CA 19-9 and CEA have virtually a role as tumor markers in peritoneal mesothelioma, the CA 19-9 is commonly elevated in gastric cancer and pancreatic (3.8%) and CEA in colorectal cancer (0%). However, they can be used to provide additional information when trying to exclude other tumors of gastric, pancreatic and colon. (more…)

Tags: , , , ,
Posted in Diagnosis, Peritoneal Mesothelioma | No Comments »